Hemoglobin, platelets, bleeding, pericardial effusions, and intrapulmonary shunting top the monitoring list for patients with pulmonary arterial hypertension (PAH) starting with sotatercept, according to Vallerie McLaughlin, MD.
Press Release|Articles|May 1, 2026
Upcoming NCPA Events for Pharmacy Teams: May, June, and July 2026
Listen
0:00 / 0:00
Key Takeaways
- May virtual Learning Hours cover HRT clinical/business integration, Pharmacy Care at Home operationalization including CMS LTC requirements and billing, and communication-science techniques for challenging patient encounters.
- June 25 virtual certificate training targets point-of-care test-and-treat program development for influenza, Group A strep, HIV, hepatitis C, coronaviruses, and chronic diseases.
Advertisement
ALEXANDRIA, Va. (May 1, 2026) – The National Community Pharmacists Association is pleased to announce these upcoming online events and trainings for pharmacists and pharmacy team members:
- May 7 – Opportunities in Hormone Replacement Therapy, Part 1: Clinical Essentials and Business Strategies, part of our NCPA Learning Hour series. Capitalize on the growing demand for personalized care with a strategic deep dive into hormone replacement therapy (HRT). Walk away with dosing strategies and a clear roadmap to integrate HRT services into your practice for both clinical impact and business growth.
Learn more and register. - May 21 – Delivering Effective Long-Term Pharmacy Care at Home: Standard, Services, and Strategies, part of our NCPA Learning Hour series. Learn how to operationalize Pharmacy Care at Home — from navigating CMS LTC requirements and identifying eligible patients to unlocking sustainable reimbursement through proper billing strategies.
Learn more and register.
- May 28 – Pause, Connect, Respond: Navigating Challenging Patient Conversations, part of our NCPA Learning Hour series. Utilizing communication science, learn how to pause before reacting, connect with patients through empathy and curiosity, and respond professionally while supporting patient care and team well-being.
Learn more and register. - June 25 – Pharmacy-Based Point-of-Care Test and Treat National Certificate Program, taking place virtually. This training provides an opportunity to gain the skills and information necessary to develop a testing program for diseases such as influenza, Group A Streptococcus, HIV, Hepatitis C, coronaviruses, and chronic diseases.
Learn more and register.
Additionally, registration is open for the following in-person events:
- June 12-13 – Business of Long-Term Care Workshop, taking place in Alexandria, Va. This is an intensive crash course on owning and operating a long-term care pharmacy. It will help attendees get started and grow their LTC offering from a few to a few thousand patients.
Learn more and register by May 26. - July 11-12 – Pharmacy Ownership Workshop, sponsored by McKesson and in part by First Financial Bank and Pharmacists Mutual Companies, taking place in Chicago, Ill. An intensive two-day event for pharmacists considering pharmacy ownership or current owners looking to polish their management skills.
Learn more and register by June 30.
Events are subject to change. Visit our website for the latest information on NCPA events.
Advertisement
Related to this article
Marie-Claire Seeley, RN, MNurs, PhD, discusses standing tests, medication review, and what inflammatory findings may mean for future POTS treatment.
FDA clears tiratricol for MCT8 deficiency, lowering dangerous T3 and outlining dosing, lab testing, and pharmacy access.
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
A single infusion reversed new-onset type 1 diabetes (T1D) in more than half of treated mice by strengthening regulatory T cells and driving autoreactive CD8+ T cells into a less destructive state.
A detailed LINKER-MM1 analysis found that cytokine release syndrome (CRS) with linvoseltamab occurred early, was predominantly low grade, and became less frequent with successive step-up and full doses.
Approval spans early and levodopa-treated disease; a 6-week titration and CYP3A interactions put pharmacists at the center of starting therapy.
In a Pharmacy Times interview, study coauthor William J. Peppard, PharmD, discusses the association between suzetrigine and fewer opioid refills after knee replacement, the limits of the evidence, and the access barriers pharmacists can help patients navigate.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease
2
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
3
CagriSema Tops Tirzepatide 5 mg for Weight Loss in REIMAGINE 5
4
Why 5 Injectable Drugs Have Been in Shortage for More Than a Decade
5